<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-NC6VERQM</identifier><date>1993</date><creator>Novaković, Srdjan</creator><creator>Rudolf, Zvonimir</creator><relation>documents/doc/N/URN_NBN_SI_doc-NC6VERQM_001.pdf</relation><relation>documents/doc/N/URN_NBN_SI_doc-NC6VERQM_001.txt</relation><format format_type="volume">27</format><format format_type="issue">4</format><format format_type="type">article</format><format format_type="extent">str. 298-301</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">61066752</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-NC6VERQM</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>InC</rights><subject language_type_id="slv">biokemija</subject><subject language_type_id="slv">interleukini</subject><subject language_type_id="slv">rak (medicina)</subject><title>Serum interleukin-2 levels in malignant melanoma patients</title></Record>